Huch, Meritxell <br/><br/>
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  Jun 2009 
 - 518-28, 4 p following 528 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1593/neo.81674  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Adenovirus E1A Proteins--genetics<br/>Animals<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Survival<br/>Gene Expression Regulation<br/>Green Fluorescent Proteins--genetics<br/>Humans<br/>Liver--metabolism<br/>Liver Neoplasms, Experimental--secondary<br/>Luciferases--genetics<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>NIH 3T3 Cells<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Pancreatic Neoplasms--pathology<br/>Promoter Regions, Genetic--genetics<br/>Receptors, Urokinase Plasminogen Activator--genetics<br/>Tumor Burden<br/>Xenograft Model Antitumor Assays